Results
Charts were available for 509 patients (98%), 68 (13%) of whom underwent cholecystectomy before transplantation. Of the 509, 53 (10%) had serial ultrasound examinations and 29 of the 53 (55%) developed gallstones. After transplant, 47 (9%) underwent cholecystectomy. Five cholecystectomies were performed during the immediate postoperative course. Two patients who underwent cholecystectomy had acalculous cholecystitis; one was incidental. Four patients died (one with rejection and three with sepsis). After discharge, 42 cholecystectomies were performed: 16 for biliary colic (no deaths, three patients with complications), 19 for acute cholecystitis (one death, nine patients with complications), 5 for biliary pancreatitis (1 death, 1 patient with complications), and 2 others.
Conclusions
The risk of morbidity and mortality from gallstone disease is high in cardiac transplant patients, particularly immediately posttransplant. Posttransplant patients require annual ultrasound examinations to detect the onset of gallstone disease, and this risk is higher than in the general population. Gallstones alone are an indication for cholecystectomy in the cardiac transplant patient. Pretransplant cholecystectomy should be considered in clinically stable patients with gallstones.
The first laparoscopic cholecystectomy was performed in the United States in 1988. Since then the rate of cholecystectomy has risen, and approximately 500,000 cholecystectomies are performed in the United States each year. 1 The increase in acceptance of this procedure is due to the shortened recovery compared with open cholecystectomy.
As with many procedures, there are no large prospective randomized studies of open versus laparoscopic cholecystectomy, but the laparoscopic procedure has become the gold standard. Laparoscopic cholecystectomy can be performed relatively safely on patients with severe cardiac disease and patients after cardiac transplant. [2] [3] [4] [5] [6] [7] The optimal timing of surgery and indications in the cardiac transplant patient remain controversial.
We retrospectively reviewed our large experience to understand the morbidity of cholecystectomy in heart transplant patients with the goal of creating a clinical strategy for identifying and treating cholelithiasis in these patients. We have included our current perioperative management of heart transplant patients and our current treatment strategy.
METHODS
Between April 1985 and October 2000, 518 cardiac transplantations were performed at the Ochsner Foundation Hospital. Charts for nine patients were unavailable. From the 509 available charts we determined the results of abdominal ultrasounds and if cholecystectomy was performed before transplant. If cholecystectomy was performed after transplant, the following were noted: age, sex, race, date of cholecystectomy, left ventricular ejection fraction (EF) at time of cholecystectomy, indication for cholecystectomy, procedure for cholecystectomy, operative time, gallbladder pathology, length of hospital stay, complications, readmissions, and deaths.
Operative Management
Compared with other patients undergoing general anesthesia, anesthetic management in patients with good allograft function is similar except that atropine is not used and bagosists (isoproteronol) is kept nearby. The Ochsner Cardiac Transplant Program practices triple-drug immunosuppression using a calcineurin (cyclosporine, tacrolimus), corticosteroids, and either adjunctive azathioprine or mycophenolate mofetil. Actuarial survival rates in the program are 89% at 1 year, 80% at 3 years, and 75% at 5 years.
RESULTS
Due to our observation of excess morbidity associated with cholelithiasis, pretransplant surveillance for gallbladder disease has been practiced universally since 1996. However, posttransplant surveillance is not routinely practiced, and abdominal ultrasonography was performed posttransplant in the series only at the discretion of the transplant physician, largely due to the development of symptoms.
Sixty-eight patients (13%) had gallbladder surgery before transplant. One hundred twenty-three patients (23.7%) had no ultrasound and no history of cholecystectomy. An initial ultrasound showed gallstones or sludge in 114 (22%). No gallstones were noted on initial ultrasound in the remaining 204 (39%).
Fifty-three (10%) had multiple postoperative ultrasounds. Of these, 29 (6%) developed gallstones. After transplant 55% developed gallstones. No follow-up ultrasounds were performed for 456 (90%).
After transplant, 47 patients (9%) (35 men, 12 women) underwent cholecystectomy. Their average age was 54 Ϯ 12 years (range 25-74). Thirty-seven were white, eight African American, and two Hispanic. Eleven patients had elevated serum cholesterol levels.
Five cholecystectomies were performed during the immediate transplant hospitalization. Four deaths occurred in this group. He was re-explored 3 days later for bleeding. In this group two patients had cholelithiasis, one had choledocholithiasis (presumably originally from gallstones) but not cholelithiasis, one had gallbladder sludge, and one had no gallstones. Table 1 summarizes morbidity and mortality for the patients who had cholecystectomy after discharge (40 at our institution and 2 at outside facilities). Sixteen patients were operated on for biliary colic. All had EFs greater than 45% (data missing for one patient). Mean operating time was 54 Ϯ 12 minutes. Length of hospital stay was outpatient for one patient, 1 day for 12 patients, and one patient each for 2 days (because of acute cholecystitis found at operation), 3 days (to control arrhythmia), and 6 days (because of ileus). One patient who stayed 1 day was readmitted for treatment of depression. Pathologic specimens showed gallstones in 13, cholesterolosis in 2, and only chronic cholecystitis in 1.
Nineteen patients were operated on for acute cholecystitis. In all but two patients the EF was above 40%. Mean operating time for the four open procedures was 94 Ϯ 36 minutes. Mean length of hospital stay was 6 days (range 4 -13), except for the patient who died on postoperative day 8 of acute respiratory distress syndrome, cytomegalovirus, and amiodarone toxicity. The patient who stayed 13 days had sepsis and acute renal failure. Of the 15 patients operated on laparoscopically, 2 required open cholecystectomy. Mean length of operative procedure was 95 Ϯ 38 minutes, including the converted cases (data missing for two patients), and mean length of hospital stay was 5 Ϯ 5 days, except for one patient who stayed 4 months (because of respiratory failure and renal failure). Hospital stay was increased for intravenous antibiotic to treat cholecystitis. In addition, two patients had postoperative renal failure, one had rejection, and three were readmitted (one for rejection, one for rehydration, and one for pneumonia and renal fail- ure). None of these patients died. Results of pathologic examination revealed 16 patients with cholecystitis (2 with acalculous cholecystitis) and 1 with cholelithiasis; two reports were missing. Of five patients operated on for biliary pancreatitis, three had acute cholecystitis and two had a history of biliary colic. All had a normal EF. Two had preoperative ERCP. One had ERCP 6 years postoperatively. Only one cholecystectomy was performed by the open approach (155 minutes). Mean length of the four laparoscopic procedures was 74 Ϯ 33 minutes. Mean length of hospital stay was 2 days (range 1-4), with the exception of one death 4 days postoperatively of unknown causes.
One patient was operated on laparoscopically for chronic cholecystitis, stayed 1 hospital day (length of procedure unknown), and had no complications. One patient operated on laparoscopically for unknown indications had an EF of 60%, was readmitted postoperatively with pancreatitis and disseminated intravascular coagulation, and died 27 days postoperatively.
DISCUSSION
Compared with the general population, our study population appeared to exhibit an increased risk for gallstone disease: 13% had preoperative and 9% postoperative cholecystectomy. The incidence of gallstones or sludge preoperatively was 22%; other studies show an incidence in the general population of 9%. 8 Our data showed a high incidence of gallstone formation after transplant (55%). These data may be confounded since these studies were partially obtained because of symptoms and not routinely. However, several other groups have also concluded that this is a high-risk population. 2, 7 In mid-1998 we began using tacrolimus in 90% of our patients. Scientifically this may reduce the risk of gallstones; however, we did not have enough patients in this group to make any conclusions. 9 The risk for gallstone disease was very high for patients who developed biliary tract disease during hospitalization for transplant. Indeed, the risk of mortality (omitting the patient with the normal cholecystectomy) was 2.6% in this group. Several studies have shown that laparoscopic cholecystectomy is safe (with aggressive monitoring) in high-risk cardiac patients. [2] [3] [4] It is not well documented whether cholecystectomy is safer in patients on the transplant list or posttransplant. In fact, Menegaux et al. found no complications when patients did not undergo cholecystectomy pretransplant even when they were symptomatic. 5 However, the number of cases in their study was small. It is difficult for us to perform cholecystectomy pretransplant because many patients are urgently brought to transplant with no time for cholecystectomy. The majority of patients undergoing cardiac transplantation at our center do so in "urgent" status and are typically refractory to oral medical therapy. Such patients often await transplant in an ICU area bound to intravenous inotropic therapy or mechanical cardiac sup-port, and it is usually not feasible to perform elective cholecystectomy before transplant because of the excessive perioperative risk. Left ventricular assist device (LVAD) implant or explant is an opportunity for cholecystectomy, but it has not been our practice to do so. Most of our patients have been too unstable at LVAD implantation to add this procedure on. Theoretically, cholecystectomy could cause bacteremia, which might affect the LVAD implant or transplanted heart, although we believe this has not been seen in practice. Further, we currently place LVADs preperitoneally, and cholecystectomy would therefore involve opening another body cavity.
The results of the present study agree with those of our prior study 7 and others 2 that laparoscopic cholecystectomy is safe when cardiac transplant patients do not have acute cholecystitis. Recently, we have increased the frequency of performing laparoscopic cholecystectomy on an outpatient basis and have rarely seen complications from perioperative hemodynamic changes.
Compared with patients with biliary colic, outcomes for patients with acute cholecystitis after transplant were much worse: increased operative time, length of hospital stay, complications, and death. Postoperative courses for laparoscopic or open surgery were similar, as Gupta et al. also found. 2 However, Lord et al. found only 13.8% morbidity and no mortality in their series, which combined patients with biliary colic and those with acute cholecystitis. 10 They concluded that there was no increased risk of waiting for symptoms to occur before cholecystectomy was performed. Our data suggest that their morbidity would be decreased if they were operating on fewer patients with acute cholecystitis.
In patients with biliary colic, our data compare well with those of the general population. However, in our patients with acute cholecystitis, the results are much worse. Our major morbidity was 47% compared with 4.4% and mortality was 0.5% compared with 0% for acute cholecystitis in the general population. 11 Severe pancreatitis carried a high risk of death. When mild, we treated it the same as in nontransplant patients, with good results. Cholangiograms should be performed to indicate the necessity of treating retained stones and to prevent them from becoming symptomatic.
Because of the high morbidity and mortality of gallstones in cardiac transplant patients, we now routinely perform annual ultrasounds to look for gallstones. When they are found, elective cholecystectomy is performed as long as allograft function is good.
CONCLUSIONS
Cardiac transplant recipients demonstrate a higher risk of de novo cholelithiasis than the general population both before and after transplantation. Because of the high morbidity and mortality risk in the immediate posttransplant period, strong consideration needs to be given to pretransplant cholecystectomy. Cholecystectomy is safe postoperatively as long as the allo-graft functions well and acute cholecystitis has not occurred. Annual surveillance for gallstones and cholecystectomy for asymptomatic gallstones are warranted.
